Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome

Background. The diagnostic and prognostic role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in heart failure is well established. However, additional factors may influence its concentration. One of them is obesity, which in general is accompanied by reduced NT-proBNP levels. However, spe...

Full description

Saved in:
Bibliographic Details
Main Authors: Paweł Krzesiński, Wiesław Piechota, Katarzyna Piotrowicz, Grzegorz Gielerak, Agnieszka Woźniak-Kosek
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/8571795
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561256181006336
author Paweł Krzesiński
Wiesław Piechota
Katarzyna Piotrowicz
Grzegorz Gielerak
Agnieszka Woźniak-Kosek
author_facet Paweł Krzesiński
Wiesław Piechota
Katarzyna Piotrowicz
Grzegorz Gielerak
Agnieszka Woźniak-Kosek
author_sort Paweł Krzesiński
collection DOAJ
description Background. The diagnostic and prognostic role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in heart failure is well established. However, additional factors may influence its concentration. One of them is obesity, which in general is accompanied by reduced NT-proBNP levels. However, specific data concerning metabolic syndrome (MS) are equivocal. The aim of the present study was to evaluate the association of NT-proBNP with estimated insulin resistance (eIR) in men with MS. Methods. In 86 male patients with MS (78 of them hypertensive), blood pressure, anthropometric measures, NT-proBNP, creatinine, glucose, and insulin were assessed and eIR was calculated using homeostatic model assessment (HOMA-IR). Results. Both eIR and age were independently associated with NT-proBNP concentrations (b = 0.2248, p=0.019; b = 0.0102, p=0.049, respectively). Blood pressure, anthropometric measures, and eGFR were not correlated with NT-proBNP. Patients without eIR had higher NT-proBNP than those with eIR (32.2 ± 26.4 vs 21.4 ± 25.4 pg/mL, p=0.014). The difference was even higher in the younger subgroup of patients reaching nearly 50%. Conclusions. Insulin resistance and, to a lesser degree, age were associated with NT-proBNP levels in men with MS. In younger subjects with eIR, mean NT-proBNP level was lower than in corresponding healthy age males.
format Article
id doaj-art-e5644e4a8ab14a609bc250d8ffef44b5
institution Kabale University
issn 2090-8016
2090-0597
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-e5644e4a8ab14a609bc250d8ffef44b52025-02-03T01:25:37ZengWileyCardiology Research and Practice2090-80162090-05972019-01-01201910.1155/2019/85717958571795Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic SyndromePaweł Krzesiński0Wiesław Piechota1Katarzyna Piotrowicz2Grzegorz Gielerak3Agnieszka Woźniak-Kosek4Department of Cardiology and Internal Diseases, Military Institute of Medicine, Szaserów Street 128, 04-141 Warsaw, PolandDepartment of Laboratory Diagnostics, Military Institute of Medicine, Szaserów Street 128, 04-141 Warsaw, PolandDepartment of Cardiology and Internal Diseases, Military Institute of Medicine, Szaserów Street 128, 04-141 Warsaw, PolandDepartment of Cardiology and Internal Diseases, Military Institute of Medicine, Szaserów Street 128, 04-141 Warsaw, PolandDepartment of Laboratory Diagnostics, Military Institute of Medicine, Szaserów Street 128, 04-141 Warsaw, PolandBackground. The diagnostic and prognostic role of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in heart failure is well established. However, additional factors may influence its concentration. One of them is obesity, which in general is accompanied by reduced NT-proBNP levels. However, specific data concerning metabolic syndrome (MS) are equivocal. The aim of the present study was to evaluate the association of NT-proBNP with estimated insulin resistance (eIR) in men with MS. Methods. In 86 male patients with MS (78 of them hypertensive), blood pressure, anthropometric measures, NT-proBNP, creatinine, glucose, and insulin were assessed and eIR was calculated using homeostatic model assessment (HOMA-IR). Results. Both eIR and age were independently associated with NT-proBNP concentrations (b = 0.2248, p=0.019; b = 0.0102, p=0.049, respectively). Blood pressure, anthropometric measures, and eGFR were not correlated with NT-proBNP. Patients without eIR had higher NT-proBNP than those with eIR (32.2 ± 26.4 vs 21.4 ± 25.4 pg/mL, p=0.014). The difference was even higher in the younger subgroup of patients reaching nearly 50%. Conclusions. Insulin resistance and, to a lesser degree, age were associated with NT-proBNP levels in men with MS. In younger subjects with eIR, mean NT-proBNP level was lower than in corresponding healthy age males.http://dx.doi.org/10.1155/2019/8571795
spellingShingle Paweł Krzesiński
Wiesław Piechota
Katarzyna Piotrowicz
Grzegorz Gielerak
Agnieszka Woźniak-Kosek
Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome
Cardiology Research and Practice
title Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome
title_full Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome
title_fullStr Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome
title_full_unstemmed Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome
title_short Association of Estimated Insulin Resistance with N-Terminal B-Type Natriuretic Peptide Concentration in Men with Metabolic Syndrome
title_sort association of estimated insulin resistance with n terminal b type natriuretic peptide concentration in men with metabolic syndrome
url http://dx.doi.org/10.1155/2019/8571795
work_keys_str_mv AT pawełkrzesinski associationofestimatedinsulinresistancewithnterminalbtypenatriureticpeptideconcentrationinmenwithmetabolicsyndrome
AT wiesławpiechota associationofestimatedinsulinresistancewithnterminalbtypenatriureticpeptideconcentrationinmenwithmetabolicsyndrome
AT katarzynapiotrowicz associationofestimatedinsulinresistancewithnterminalbtypenatriureticpeptideconcentrationinmenwithmetabolicsyndrome
AT grzegorzgielerak associationofestimatedinsulinresistancewithnterminalbtypenatriureticpeptideconcentrationinmenwithmetabolicsyndrome
AT agnieszkawozniakkosek associationofestimatedinsulinresistancewithnterminalbtypenatriureticpeptideconcentrationinmenwithmetabolicsyndrome